Your browser doesn't support javascript.
loading
MSC-Delivered Soluble TRAIL and Paclitaxel as Novel Combinatory Treatment for Pancreatic Adenocarcinoma.
Rossignoli, Filippo; Spano, Carlotta; Grisendi, Giulia; Foppiani, Elisabetta Manuela; Golinelli, Giulia; Mastrolia, Ilenia; Bestagno, Marco; Candini, Olivia; Petrachi, Tiziana; Recchia, Alessandra; Miselli, Francesca; Rovesti, Giulia; Orsi, Giulia; Veronesi, Elena; Medici, Gregorio; Petocchi, Benedetta; Pinelli, Massimo; Horwitz, Edwin M; Conte, Pierfranco; Dominici, Massimo.
Affiliation
  • Rossignoli F; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Spano C; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Grisendi G; Rigenerand srl, Medolla, Modena.
  • Foppiani EM; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Golinelli G; Rigenerand srl, Medolla, Modena.
  • Mastrolia I; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Bestagno M; Rigenerand srl, Medolla, Modena.
  • Candini O; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Petrachi T; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Recchia A; International Centre for Genetic Engineering and Biotechnology, Trieste, Italy.
  • Miselli F; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Rovesti G; Rigenerand srl, Medolla, Modena.
  • Orsi G; Technopole of Mirandola TPM, Mirandola, Modena.
  • Veronesi E; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Medici G; Department of Life Sciences, University of Modena and Reggio Emilia, Modena, Italy.
  • Petocchi B; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Pinelli M; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Horwitz EM; Division of Oncology, Department of Medical and Surgical Sciences for Children & Adults, University-Hospital of Modena and Reggio Emilia, Modena, Italy.
  • Conte P; Technopole of Mirandola TPM, Mirandola, Modena.
  • Dominici M; Pharmacy Unit.
Theranostics ; 9(2): 436-448, 2019.
Article in En | MEDLINE | ID: mdl-30809285
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Paclitaxel / Combined Modality Therapy / TNF-Related Apoptosis-Inducing Ligand / Cell- and Tissue-Based Therapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Theranostics Year: 2019 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Adenocarcinoma / Paclitaxel / Combined Modality Therapy / TNF-Related Apoptosis-Inducing Ligand / Cell- and Tissue-Based Therapy / Antineoplastic Agents Type of study: Prognostic_studies Limits: Animals / Humans Language: En Journal: Theranostics Year: 2019 Document type: Article Affiliation country: Country of publication: